Legis Daily

Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020

USA116th CongressS-3384| Senate 
| Updated: 3/3/2020
Martha McSally

Martha McSally

Republican Senator

Arizona

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 This bill makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 3, 2020
Introduced in Senate
Mar 3, 2020
Read twice and referred to the Committee on Finance.
  • March 3, 2020
    Introduced in Senate


  • March 3, 2020
    Read twice and referred to the Committee on Finance.

Health

Related Bills

  • HR 116-2455: Ensuring Timely Access to Generics Act of 2019
  • HR 116-478: Safe and Affordable Drugs from Canada Act of 2019
  • S 116-1224: Stop STALLING Act
  • S 116-1169: Ensuring Timely Access to Generics Act of 2019
  • HR 116-2374: Stop STALLING Act
  • S 116-61: Safe and Affordable Drugs from Canada Act of 2019
  • S 116-64: Preserve Access to Affordable Generics and Biosimilars Act
Administrative law and regulatory proceduresAdministrative remediesBusiness ethicsCanadaCivil actions and liabilityCompetition and antitrustDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFederal Trade Commission (FTC)Food and Drug Administration (FDA)Government information and archivesHealth care costs and insuranceHealth information and medical recordsInflation and pricesIntellectual propertyLicensing and registrationsManufacturingMedicarePrescription drugsPublic participation and lobbyingTrade restrictions

Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020

USA116th CongressS-3384| Senate 
| Updated: 3/3/2020
Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 This bill makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 3, 2020
Introduced in Senate
Mar 3, 2020
Read twice and referred to the Committee on Finance.
  • March 3, 2020
    Introduced in Senate


  • March 3, 2020
    Read twice and referred to the Committee on Finance.
Martha McSally

Martha McSally

Republican Senator

Arizona

Finance Committee

Health

Related Bills

  • HR 116-2455: Ensuring Timely Access to Generics Act of 2019
  • HR 116-478: Safe and Affordable Drugs from Canada Act of 2019
  • S 116-1224: Stop STALLING Act
  • S 116-1169: Ensuring Timely Access to Generics Act of 2019
  • HR 116-2374: Stop STALLING Act
  • S 116-61: Safe and Affordable Drugs from Canada Act of 2019
  • S 116-64: Preserve Access to Affordable Generics and Biosimilars Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAdministrative remediesBusiness ethicsCanadaCivil actions and liabilityCompetition and antitrustDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFederal Trade Commission (FTC)Food and Drug Administration (FDA)Government information and archivesHealth care costs and insuranceHealth information and medical recordsInflation and pricesIntellectual propertyLicensing and registrationsManufacturingMedicarePrescription drugsPublic participation and lobbyingTrade restrictions